Prospective Phase II Single-Center Study of the Safety of a Single Very High Dose of Liposomal Amphotericin B for Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00155-13
Full Text
Open PDFAbstract
Available in full text
Date
March 25, 2013
Authors
Publisher
American Society for Microbiology